Unknown NA INTERVENTIONAL 4-arm NCT03604848

NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB (GRACE-TB)

GRACE-TB：NGS-guided Regimens of Anti-tuberculosis Drugs for the Control and Eradication of MDR-TB

Sponsor: Huashan Hospital

Conditions Multidrug Resistant Tuberculosis

Interventions NGS-guided regimen: Regimen A NGS-guided regimen: Regimen B NGS-guided regimen: Regimen C WHO-approved MDR-TB regimen

Updated 5 times since 2018 Last updated: Jul 19, 2018 Started: Aug 5, 2018 Primary completion: Aug 4, 2024 Completion: Aug 4, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Multidrug Resistant Tuberculosis and is currently ongoing. Huashan Hospital leads this study, which shows 5 recorded versions since 2018 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown NA
Sep 2024 — Sep 2025 [monthly]

Unknown NA

Status: Not Yet Recruiting → Unknown
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Jan 2021 — Jul 2024 [monthly]

Not Yet Recruiting NA
Aug 2018 — Jan 2021 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Huashan Hospital

Data source: Huashan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Hangzhou, China , Harbin, China , Luzhou, China , Ningbo, China , Shenzhen, China , Suzhou, China , Taizhou, China , Wenzhou, China , Zhengzhou, China , Zhuji, China and 1 more location